Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide

Prevention of amyloid β peptide (Aβ) deposition via facilitation of Aβ binding to its natural depot, human serum albumin (HSA), is a promising approach to preclude Alzheimer’s disease (AD) onset and progression. Previously, we demonstrated the ability of natural HSA ligands, fatty acids, to improve...

Full description

Bibliographic Details
Main Authors: Ekaterina A. Litus, Alexey S. Kazakov, Evgenia I. Deryusheva, Ekaterina L. Nemashkalova, Marina P. Shevelyova, Aliya A. Nazipova, Maria E. Permyakova, Elena V. Raznikova, Vladimir N. Uversky, Sergei E. Permyakov
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/11/5896
_version_ 1797531943285293056
author Ekaterina A. Litus
Alexey S. Kazakov
Evgenia I. Deryusheva
Ekaterina L. Nemashkalova
Marina P. Shevelyova
Aliya A. Nazipova
Maria E. Permyakova
Elena V. Raznikova
Vladimir N. Uversky
Sergei E. Permyakov
author_facet Ekaterina A. Litus
Alexey S. Kazakov
Evgenia I. Deryusheva
Ekaterina L. Nemashkalova
Marina P. Shevelyova
Aliya A. Nazipova
Maria E. Permyakova
Elena V. Raznikova
Vladimir N. Uversky
Sergei E. Permyakov
author_sort Ekaterina A. Litus
collection DOAJ
description Prevention of amyloid β peptide (Aβ) deposition via facilitation of Aβ binding to its natural depot, human serum albumin (HSA), is a promising approach to preclude Alzheimer’s disease (AD) onset and progression. Previously, we demonstrated the ability of natural HSA ligands, fatty acids, to improve the affinity of this protein to monomeric Aβ by a factor of 3 (BBRC, 510(2), 248–253). Using plasmon resonance spectroscopy, we show here that another HSA ligand related to AD pathogenesis, serotonin (SRO), increases the affinity of the Aβ monomer to HSA by a factor of 7/17 for Aβ<sub>40</sub>/Aβ<sub>42</sub>, respectively. Meanwhile, the structurally homologous SRO precursor, tryptophan (TRP), does not affect HSA’s affinity to monomeric Aβ, despite slowdown of the association and dissociation processes. Crosslinking with glutaraldehyde and dynamic light scattering experiments reveal that, compared with the TRP-induced effects, SRO binding causes more marked changes in the quaternary structure of HSA. Furthermore, molecular docking reveals distinct structural differences between SRO/TRP complexes with HSA. The disintegration of the serotonergic system during AD pathogenesis may contribute to Aβ release from HSA in the central nervous system due to impairment of the SRO-mediated Aβ trapping by HSA.
first_indexed 2024-03-10T10:52:00Z
format Article
id doaj.art-bd22e6b9c6eb4bdb811d289be5e5dbc3
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T10:52:00Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bd22e6b9c6eb4bdb811d289be5e5dbc32023-11-21T22:12:09ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-05-012211589610.3390/ijms22115896Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β PeptideEkaterina A. Litus0Alexey S. Kazakov1Evgenia I. Deryusheva2Ekaterina L. Nemashkalova3Marina P. Shevelyova4Aliya A. Nazipova5Maria E. Permyakova6Elena V. Raznikova7Vladimir N. Uversky8Sergei E. Permyakov9Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaDepartment of Molecular Medicine and USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USAInstitute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino, 142290 Moscow, RussiaPrevention of amyloid β peptide (Aβ) deposition via facilitation of Aβ binding to its natural depot, human serum albumin (HSA), is a promising approach to preclude Alzheimer’s disease (AD) onset and progression. Previously, we demonstrated the ability of natural HSA ligands, fatty acids, to improve the affinity of this protein to monomeric Aβ by a factor of 3 (BBRC, 510(2), 248–253). Using plasmon resonance spectroscopy, we show here that another HSA ligand related to AD pathogenesis, serotonin (SRO), increases the affinity of the Aβ monomer to HSA by a factor of 7/17 for Aβ<sub>40</sub>/Aβ<sub>42</sub>, respectively. Meanwhile, the structurally homologous SRO precursor, tryptophan (TRP), does not affect HSA’s affinity to monomeric Aβ, despite slowdown of the association and dissociation processes. Crosslinking with glutaraldehyde and dynamic light scattering experiments reveal that, compared with the TRP-induced effects, SRO binding causes more marked changes in the quaternary structure of HSA. Furthermore, molecular docking reveals distinct structural differences between SRO/TRP complexes with HSA. The disintegration of the serotonergic system during AD pathogenesis may contribute to Aβ release from HSA in the central nervous system due to impairment of the SRO-mediated Aβ trapping by HSA.https://www.mdpi.com/1422-0067/22/11/5896Alzheimer’s diseasehuman serum albuminamyloid β peptideserotonintryptophansurface plasmon resonance
spellingShingle Ekaterina A. Litus
Alexey S. Kazakov
Evgenia I. Deryusheva
Ekaterina L. Nemashkalova
Marina P. Shevelyova
Aliya A. Nazipova
Maria E. Permyakova
Elena V. Raznikova
Vladimir N. Uversky
Sergei E. Permyakov
Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
International Journal of Molecular Sciences
Alzheimer’s disease
human serum albumin
amyloid β peptide
serotonin
tryptophan
surface plasmon resonance
title Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
title_full Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
title_fullStr Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
title_full_unstemmed Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
title_short Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
title_sort serotonin promotes serum albumin interaction with the monomeric amyloid β peptide
topic Alzheimer’s disease
human serum albumin
amyloid β peptide
serotonin
tryptophan
surface plasmon resonance
url https://www.mdpi.com/1422-0067/22/11/5896
work_keys_str_mv AT ekaterinaalitus serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT alexeyskazakov serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT evgeniaideryusheva serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT ekaterinalnemashkalova serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT marinapshevelyova serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT aliyaanazipova serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT mariaepermyakova serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT elenavraznikova serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT vladimirnuversky serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide
AT sergeiepermyakov serotoninpromotesserumalbumininteractionwiththemonomericamyloidbpeptide